Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 19, 2010Molecular CancerOpen Access

Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl

View Full Paper
Ask AI
Bookmark
Share

Authors

ZLZhongzheng LuBeijing Normal UniversityYJYanli JinJinan UniversityCCChun ChenWilmington University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lu et al. (2010) studied this question.

synapsesocial.com/papers/6a9aa1ff53362da04b0e5d6fhttps://doi.org/10.1186/1476-4598-9-112
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species2010 · 337 citations
  2. 2Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages1995 · 189 citations
  3. 3A novel NF- B inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors2004 · 170 citations